FDA approves new drug to treat migraines

Monday, December 23, 2019 - 17:20 in Health & Medicine

Migraine sufferers who cannot get relief from existing medications have a new treatment option -- a pill called ubrogepant (Ubrelvy), the U.S. Food and Drug Administration announced Monday.

Read the whole article on UPI

More from UPI

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net